Adial Pharmaceuticals Inc (ADIL) concluded trading on Wednesday at a closing price of $2.33, with 105.14 million shares of worth about $244.98 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -17.38% during that period and on April 10, 2024 the price saw a gain of about 106.19%. Currently the company’s common shares owned by public are about 4.05M shares, out of which, 3.67M shares are available for trading.
Stock saw a price change of 87.90% in past 5 days and over the past one month there was a price change of 16.50%. Year-to-date (YTD), ADIL shares are showing a performance of 25.27% which decreased to -67.83% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.76 but also hit the highest price of $14.00 during that period. The average intraday trading volume for Adial Pharmaceuticals Inc shares is 4.01 million. The stock is currently trading 59.62% above its 20-day simple moving average (SMA20), while that difference is up 60.11% for SMA50 and it goes to -17.97% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Adial Pharmaceuticals Inc (NASDAQ: ADIL) currently have 4.05M outstanding shares and institutions hold larger chunk of about 6.55% of that.
The stock has a current market capitalization of $9.44M and its 3Y-monthly beta is at 1.54. It has posted earnings per share of -$6.43 in the same period. It has Quick Ratio of 4.90 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ADIL, volatility over the week remained 19.00% while standing at 16.25% over the month.
Analysts are in expectations that Adial Pharmaceuticals Inc (ADIL) stock would likely to be making an EPS of -$0.35 in the current quarter, while forecast for next quarter EPS is -$0.35 and it is -$7.04 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.37 which is -$0.33 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$2.75 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 64.51% while it is estimated to increase by 15.89% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on October 30, 2018 offering a Buy rating for the stock and assigned a target price of $5 to it.
